
NVAX vs MAZE
$NVAX vs $MAZE head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
NVAX vs MAZE: the quick read
- ·NVAX is the larger company by market cap ($1.73B vs $1.47B).
- ·NVAX has been more active on our scanner (160 vs 114 alerts in 30 days).
- ·MAZE has the smaller float (52.8M vs 150.2M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) vs Biological Products, (No Diagnostic Substances)), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 160 and 114 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 18% of each other on market cap, which makes the rest of this table the interesting part.
- ·NVAX pays a dividend and MAZE does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing NVAX and MAZE on TheDesperateTrader.
- Is NVAX or MAZE the better stock?
- "Better" depends on your goal, and these two are not alike. NVAX is the larger company by market cap ($1.73B vs $1.47B). NVAX has been more active on our scanner (160 vs 114 alerts in 30 days). MAZE has the smaller float (52.8M vs 150.2M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between NVAX and MAZE?
- The differences that matter: they are not in the same business - NVAX is biological products, (no diagnostic substances) and MAZE is biological products, (no diagnostic substances); they are similar in size ($1.73B vs $1.47B); they trade at very different share prices ($10.49 vs $26.43); NVAX sits at 74% of its 52-week range against 14% for MAZE; only NVAX pays a dividend; our scanner flagged NVAX 160 times in the last 30 days against 114 for MAZE. Everything above is measured from the latest completed session and SEC filings.
- Which of NVAX and MAZE is more active right now?
- Right now NVAX is at about 0.7x its normal volume and MAZE is at about 0.9x, so MAZE is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading NVAX or MAZE? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore NVAX and MAZE comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.